Sodertalje, Sweden

Rolf Johansson

USPTO Granted Patents = 2 


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Södertälje, SE (2011)
  • Sodertalje, SE (2012)

Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rolf Johansson: Innovator in Pharmaceutical Chemistry

Introduction

Rolf Johansson is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel therapeutic compounds. With a total of 2 patents, his work focuses on innovative solutions for various medical conditions.

Latest Patents

Johansson's latest patents include the development of 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3H)-amine derivatives and their use in therapy. These compounds are designed to act as CXCR1 receptor antagonists, making them particularly useful in treating neurodegenerative disorders, demyelinating diseases, and various cardiovascular conditions. Another significant patent involves 5,7-disubstituted thiazolo[4,5-d]pyrimidines for the selective inhibition of chemokine receptors, which also targets similar medical issues.

Career Highlights

Rolf Johansson is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on the development of innovative therapies that address critical health challenges. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the research and development sector.

Collaborations

Johansson has collaborated with several esteemed colleagues, including Annika Kers and Gunnar Nordvall. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of groundbreaking therapeutic solutions.

Conclusion

Rolf Johansson's contributions to pharmaceutical chemistry through his patents and collaborations highlight his commitment to advancing medical science. His innovative work continues to pave the way for new treatments that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…